US Hispanic women have the youngest average age at breast cancer diagnosis at 57.2 years old in 2023, while White patients are diagnosed at the oldest average age at 64.5 years old. Black women are disgnosed at an average age of 61.7 years. Researchers analyzed more than 484,000 diagnoses of breast cancer between 2018 and […]
Hereditary DNA testing is recommended for all patients with Triple-Negative Breast Cancer (TNBC) to identify inherited BRCA1/BRCA2 mutations responsible for developing breast cancer and to help physicians in managing their patients’ treatment. To see who is being tested, researchers analyzed the medical records of 1,318 women diagnosed between 2017 and 2021 treated in US community oncology
Disparities in use of hereditary genetic testing in triple-negative breast cancer Read More »
Racial minorities bear a much higher cost burden than White patients for unplanned hospital visits after breast reconstruction surgery, according to a study of more than 17,000 patients. Researchers could not identify from the data they analyzed why the women had undergone breast reconstruction. Black women were charged an average of $2,840 more than White
The University of California at Irvine in 2021 set up an online portal where women could schedule screening that their healthcare provider ordered or that they requested on their own. In all, more than 22,000 women used the portal. Most likely to self-schedule were Hispanic women and women living in the most disadvantaged neighborhoods. Most
Women living in 3,712 redlined U.S. census-tracts, especially in the New York and Los Angeles metropolitan areas, were 24 percent less likely than women living in A (“Best”) areas to meet breast screening targets. Poverty, lack of education and limited English proficiency were among the most significant barriers. See “Historic redlining practices cast a long
Black and Hispanic female survivors of breast cancer experience higher death rates than White women after being diagnosed with a second primary cancer. In a study of nearly 40,000 adult survivors of breast cancer, the risk of death from a second cancer was 12 percent among Black survivors and 8 percent higher among Hispanic survivors
Less than seven percent of cancer patients in California and Georgia underwent genetic testing within two years of diagnosis, despite guidelines recommending genetic testing in the majority of patients. Allison Kurian, MD (above), of the Stanford University Medical School and her colleagues reviewed the records of nearly 1.4 million patients in California and Georgia diagnosed
Black women were 20 percent less likely than White women to receive digital mammography after its implementation in 2005, and 16 percent less likely than white women to receive digital breast tomosynthesis after its implementation in 2015. Earlier detection of breast cancer has been facilitated by major technological advances, in particularly the evolution from screen-film mammography
Black women less likely to be screened for breast cancer with latest technology Read More »
More than 20 percent of patients, and one in three Hispanic women, say they would forego follow-up tests after an abnormal mammogram if they had to pay a deductible, according to a recent survey of 714 patients at the Boston Medical Center. The study also found that 18% of respondents would abstain from breast cancer
One in three Hispanic women surveyed would skip costly follow-up breast cancer screening Read More »
The rates of triple-negative breast cancer (TNBC) among women in the United States varies substantially by race and geographic location, according to a new study of more than 133,000 women diagnosed with TNBC from 2015 through 2019. The analysis found that overall Black women were twice as likely as White women to be diagnosed with
Information provided on this website is neither intended nor implied to be a substitute for professional medical advice and is not intended to replace the services of a physician.
You should not use information on this web site or the information on links from this site to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider.
